MedPath

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Phase 2
Completed
Conditions
HIV Infections
Cancer
Pain
Registration Number
NCT00002160
Lead Sponsor
Neurex
Brief Summary

To determine the safety and efficacy of SNX-111 in controlling severe, chronic pain in cancer and AIDS patients.

Detailed Description

Patients are randomized to receive SNX-111 or placebo (AS PER AMENDMENT 1/22/98: with randomization weighted 2:1 in favor of SNX-111) via external pump and an intrathecal catheter (thin tube inserted into the spinal canal). (AS PER AMENDMENT 1/22/98: the dose is increased every 24 hours, in the absence of onset of analgesia or adverse events. After 2-5 days, patients who respond to their medication continue treatment at home for 5-8 days. Patients who do not respond will be switched to the other regimen (i.e., placebo to SNX-111, or SNX-111 to placebo). After 10 days, responding patients are unblinded and asked to enroll in the long-term, open-label extension protocol. Patients remain on a fixed dose at the therapeutic level found in the previous study. The dose may be increased or decreased at the discretion of the investigator. Patients may continue therapy on a long-term basis until the drug is approved.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (44)

Ctr for Pain Management and Rehabilitation

πŸ‡ΊπŸ‡Έ

Huntsville, Alabama, United States

Gulf Coast Clinical Services

πŸ‡ΊπŸ‡Έ

Mobile, Alabama, United States

Northport Hosp

πŸ‡ΊπŸ‡Έ

Northport, Alabama, United States

Holt Krock Clinic

πŸ‡ΊπŸ‡Έ

Fort Smith, Arkansas, United States

Alta Bates Hosp

πŸ‡ΊπŸ‡Έ

Berkeley, California, United States

Pain Diagnosis and Treatment

πŸ‡ΊπŸ‡Έ

Glendora, California, United States

Univ of CA - San Diego

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

Good Samaritan Hosp Ctr

πŸ‡ΊπŸ‡Έ

San Jose, California, United States

Connecticut Pain Care

πŸ‡ΊπŸ‡Έ

Danbury, Connecticut, United States

VA Med Ctr / Oncology Section

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Scroll for more (34 remaining)
Ctr for Pain Management and Rehabilitation
πŸ‡ΊπŸ‡ΈHuntsville, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.